Baylor College of Medicine

Enhancement of Biomarkers for Type 1 Diabetes (H-41091)

Description

Content

Study Goal(s): To utilize immunologic biomarkers, in particular a variant-specific IA-2 autoantibodies, for type 1 diabetes prediction

Eligibility Criteria: Individuals with type 1 diabetes 

Investigators: Massimo Pietropaolo, M.D. (principal investigator), Maria J. Redondo M.D., Ph.D. (co-investigator)

Supported by: National institutes of Health, R01 Award

Contact

Massimo.pietropaolo@bcm.edu

IRB: H-41091

Status:

Active

Created:

Back to topback-to-top